The importance of GLP-1 therapies for type 2 diabetes and CVD Today it is well established that excessive body fat together with lack of regular physical activity, together with a genetic predisposition, are the main causes of type 2 diabetes, contributing as well to a substantial proportion of cardiovascular diseases, cancers, and other chronic degenerative diseases
Learning to recognize early signs of low blood sugar, including shakiness, sweating, confusion, and rapid heartbeat, allows you to respond quickly
In a capsule, residual moisture content and temperature determine the rate
Eligible Medicare patients pay as little as a $50 copay for FDA-approved GLP-1s, or $140/month for compounded medications
we set expectations so you're not disappointed